Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adaptive Biotechnologies Corp | SVP and General Counsel | Common Stock | 139K | $627K | $4.50 | Aug 22, 2024 | Direct |
Adaptive Biotechnologies Corp | SVP and General Counsel | Stock Option (right to buy) | 60K | Mar 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ADPT | Adaptive Biotechnologies Corp | Aug 22, 2024 | 1 | -$121K | 4 | Aug 23, 2024 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Mar 4, 2024 | 4 | -$46K | 4 | Mar 6, 2024 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Mar 6, 2023 | 4 | -$162K | 4 | Mar 8, 2023 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Mar 8, 2022 | 1 | -$27.3K | 4 | Mar 10, 2022 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Mar 4, 2022 | 3 | -$18.8K | 4 | Mar 8, 2022 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Dec 22, 2021 | 5 | -$353K | 4 | Dec 23, 2021 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Sep 7, 2021 | 3 | -$16.6K | 4 | Sep 9, 2021 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Jun 30, 2021 | 8 | -$110K | 4 | Jul 1, 2021 | SVP and General Counsel |
ADPT | Adaptive Biotechnologies Corp | Jun 17, 2021 | 7 | -$104K | 4 | Jun 21, 2021 | SVP and General Counsel |